Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Dopaminergic lesion enhan… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Dopaminergic lesion enhances growth factor-induced striatal neuroblast migration.

Artikel i vetenskaplig tidskrift
Författare Beate Winner
Sebastien Couillard-Despres
Martin Geyer
Robert Aigner
Ulrich Bogdahn
Ludwig Aigner
Hans-Georg Kuhn
Jürgen Winkler
Publicerad i Journal of neuropathology and experimental neurology
Volym 67
Nummer/häfte 2
Sidor 105-16
ISSN 0022-3069
Publiceringsår 2008
Publicerad vid Institutionen för neurovetenskap och fysiologi, sektionen för klinisk neurovetenskap och rehabilitering
Sidor 105-16
Språk en
Länkar dx.doi.org/10.1097/nen.0b013e318163...
Ämnesord Animals, Brain Injuries, chemically induced, drug therapy, pathology, physiopathology, Cell Count, Cell Differentiation, drug effects, Cell Movement, drug effects, physiology, Cell Proliferation, drug effects, Corpus Striatum, drug effects, pathology, Disease Models, Animal, Dopamine, metabolism, Female, In Situ Nick-End Labeling, Intercellular Signaling Peptides and Proteins, administration & dosage, Nerve Tissue Proteins, metabolism, Neurons, drug effects, physiology, Oxidopamine, Rats, Rats, Wistar
Ämneskategorier Neurovetenskap

Sammanfattning

Adult neurogenesis persists in the subventricular zone and is decreased in Parkinson disease (PD). The therapeutic potential of neurogenesis in PD requires understanding of mechanisms of 1) neural stem cell generation; 2) their guidance to the lesion site; and 3) the environment that enables neuronal differentiation, survival, and functional integration. We examined the combined intraventricular infusion of epidermal growth factor (EGF) and fibroblast growth factor 2 (FGF-2) in a 6-hydroxydopamine-induced rodent model of PD. Epidermal growth factor and FGF-2 induced a massive increase in cell proliferation and in numbers of doublecortin-expressing neuroblasts in the subventricular zone. These growth factors also increased dopaminergic neurogenesis in the olfactory bulb and promoted the migration of newly generated neuroblasts from the subventricular zone into the adjacent striatum. The effects of EGF and FGF-2 were present in unlesioned animals but were dramatically enhanced in 6-hydroxydopamine-lesioned animals.These findings suggest that newly generated neuroblasts may be redirected to the region of dopaminergic deficit, and that EGF and FGF-2 can enhance dopaminergic neurogenesis in the olfactory bulb but not in the striatum. Similar mechanisms may be involved in the increased numbers of dopaminergic neurons observed in the olfactory bulbs of PD patients and their functional olfactory deficits.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?

Denna text är utskriven från följande webbsida:
http://www.gu.se/forskning/publikation/?tipFriend=true&tipUrl=http%3A%2F%2Fwww.gu.se%2Fforskning%2Fpublikation%2F%3Fprint%3Dtrue%26publicationId%3D78570&publicationId=78570
Utskriftsdatum: 2020-08-09